<code id='E392519A6A'></code><style id='E392519A6A'></style>
    • <acronym id='E392519A6A'></acronym>
      <center id='E392519A6A'><center id='E392519A6A'><tfoot id='E392519A6A'></tfoot></center><abbr id='E392519A6A'><dir id='E392519A6A'><tfoot id='E392519A6A'></tfoot><noframes id='E392519A6A'>

    • <optgroup id='E392519A6A'><strike id='E392519A6A'><sup id='E392519A6A'></sup></strike><code id='E392519A6A'></code></optgroup>
        1. <b id='E392519A6A'><label id='E392519A6A'><select id='E392519A6A'><dt id='E392519A6A'><span id='E392519A6A'></span></dt></select></label></b><u id='E392519A6A'></u>
          <i id='E392519A6A'><strike id='E392519A6A'><tt id='E392519A6A'><pre id='E392519A6A'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:726
          Matts Take Column Illustration
          Molly Ferguson for STAT

          American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.

          Sit with that like a terrible Zen koan: Medicines are both too cheap and too expensive.

          advertisement

          How is that possible? A lot of it goes back to the 1984 Hatch-Waxman Act, which set up the ecosystem that determines the process by which drugs go from being expensive brands to cheap generics in the U.S.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more
          Medicare Advantage 2025 payments will dip, Biden administration says
          Medicare Advantage 2025 payments will dip, Biden administration says

          AdobeOverthepastfewweeks,MedicareAdvantageinsurersdemandedthattheBidenadministrationgivethemhigherpa

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Readout Newsletter: The latest on Amylyx, Moderna, Novavax

          JUSTINTALLIS/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup toge